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Abstract
Background: Permethrin is the active component of topical creams widely used to treat human scabies. Recent evidence
has demonstrated that scabies mites are becoming increasingly tolerant to topical permethrin and oral ivermectin. An
effective approach to manage pesticide resistance is the addition of synergists to counteract metabolic resistance.
Synergists are also useful for laboratory investigation of resistance mechanisms through their ability to inhibit specific
metabolic pathways.
Methodology/Principal Findings: To determine the role of metabolic degradation as a mechanism for acaricide resistance
in scabies mites, PBO (piperonyl butoxide), DEF (S,S,S-tributyl phosphorotrithioate) and DEM (diethyl maleate) were first
tested for synergistic activity with permethrin in a bioassay of mite killing. Then, to investigate the relative role of specific
metabolic pathways inhibited by these synergists, enzyme assays were developed to measure esterase, glutathione S-
transferase (GST) and cytochrome P450 monooxygenase (cytochrome P450) activity in mite extracts. A statistically
significant difference in median survival time of permethrin-resistant Sarcoptes scabiei variety canis was noted when any of
the three synergists were used in combination with permethrin compared to median survival time of mites exposed to
permethrin alone (p,0.0001). Incubation of mite homogenates with DEF showed inhibition of esterase activity (37%);
inhibition of GST activity (73%) with DEM and inhibition of cytochrome P450 monooxygenase activity (81%) with PBO. A 7-
fold increase in esterase activity, a 4-fold increase in GST activity and a 2-fold increase in cytochrome P450 monooxygenase
activity were observed in resistant mites compared to sensitive mites.
Conclusions: These findings indicate the potential utility of synergists in reversing resistance to pyrethroid-based acaricides
and suggest a significant role of metabolic mechanisms in mediating pyrethroid resistance in scabies mites.
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Introduction
Scabies is an infectious skin disease caused by the ectoparasite,
Sarcoptes scabiei. The mite lives in the skin of hosts where it passes
through a series of life stages (eggs, larva, protonymph,
tritonymph, and adult). A severe manifestation of the disease i.e.,
crusted scabies can occur which may predispose to streptococcal
pyoderma and the subsequent development of acute post
streptococcal glomerulonephritis, acute rheumatic fever and
rheumatic heart disease [1]. Treatment generally entails the
application of topical creams for classical scabies, while oral
ivermectin is recommended for crusted scabies [1]. Permethrin,
used at a concentration of 5%, is the active component of topical
creams commonly used to treat the disease. Since its introduction
in Australia in 1994 for the treatment of scabies, it has been widely
used in endemic communities in mass treatment programs [2].
Recent evidence from a prospective study of in vitro acaricide
sensitivity has demonstrated increased tolerance to permethrin of
scabies mites collected from indigenous communities across
northern Australia (unpublished data).
Pyrethroids constitute one of the most important classes of
insecticide, accounting for 17% of the world insecticide market
[3]. Their intensive use worldwide over the last 30 years has led to
the development of resistance in many arthropods, such that
resistance now constitutes a serious threat to many programmes
for control of pests and ectoparasites in agriculture, veterinary and
human practice.
Various resistance mechanisms such as behavioural (avoidance
of treated surfaces), physiological (reduced penetration and/or
increased excretion of insecticides), reduced sensitivity of target site
(by target alteration) and metabolic degradation (by hyperproduc-
tion of enzymes) mediate pesticide resistance of arthropods. Target
site insensitivity and metabolic degradation have been demon-
strated to play major roles in conferring resistance to pyrethroids
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in some arthropods. In the German cockroach, Blattella germanica,
pyrethroid resistance has been demonstrated to be mediated by
multiple mechanisms including target site insensitivity, decreased
cuticular penetration, and enhanced metabolism by monooxygen-
ases and esterases [4]. The same is true for cattle ticks, a class of
arthropods more closely related to scabies mite, where a point
mutation in the kdr gene and metabolic degradation by esterases
have both been identified as mediators of pyrethroid resistance [5].
Recently, pyrethroid resistance in Italian strains of peach potato
aphid, Myzus persicae has been shown to be conferred by both
mutations in the kdr gene and hyperproduction of esterases [6].
An effective way to manage pesticide resistance is the
coformulation of synergist with the pesticide to counteract
metabolic resistance. Synergists act by blocking metabolic
pathways that would otherwise break down pesticides, thus
restoring susceptibility to the agent. Piperonyl Butoxide (PBO) is
co-formulated with insecticides such as carbaryl, methomyl,
fenvalerate, permethrin, parathion, malathion and dimethoate;
S,S,S-tributyl phosphorotrithioate (DEF) is co-formulated with
malathion and permethrin; and Diethyl maleate (DEM) is co-
formulated with parathion, malathion and dimethoate [7]. For
example, PBO has been used as a synergist to pyrethrins in
commercially available treatment for head lice (caused by Pediculus
humanus capitis) to counteract resistance. Examples of over-the –
counter treatment products for headlice are: Pronto (33%
pyrethrins and 4% PBO) (Del Laboratories, Uniondale, NY),
RID (33% pyrethrins and 4% PBO) (Bayer, Morristown, NJ), A-
200 (33% pyrethrins and 4% PBO) (Hogil Pharmaceutical Corp.,
Purchase, NY) available in the US and BanLice Mousse (pyrethrin
1.65 mg and 16.5 mg PBO) (Pfizer) available in Australia [8].
In addition, insecticide synergists have been used to investigate
resistance mechanisms and to identify the specific metabolic
pathways targeted. Tolerance of honey bees, Apis mellifera, to
pyrethroids is largely reversed by PBO and at low levels by DEF,
suggesting a significant role of cytochrome P450s and a lesser role
of esterases in detoxification of the chemical [9]. However, the
metabolic routes blocked by synergists are not yet fully understood
and maybe dependent on the species of arthropods. For example,
although initial evidence in the 1970’s suggested that PBO acts as
a specific inhibitor of monooxygenases (P450s), recently, esterases
of pyrethroid resistant strains of the cotton bollworm, (Helicoverpa
armigera) were shown to be inhibited by PBO [10]. In a study
conducted with insecticide resistant strain of the German
cockroach, Blatella germanica, PBO and DEF were tested as
synergists to propoxur (a carbamate insecticide). Both were shown
to inhibit cytochrome P450 monooxygenases at different levels
[11], thus, suggesting that this enzyme family is primarily
responsible for the metabolism of the pesticide.
Previously, we identified a single nucleotide polymorphism
(SNP) in the kdr gene associated with permethrin resistance in a
population of scabies mites [12]. In this study, the same strain of
scabies mites, Sarcoptes scabiei var canis was used to investigate the
role of metabolic degradation as a contributory mechanism to
observed permethrin resistance. PBO, DEF and DEM were tested
as synergists to permethrin to determine if susceptibility to the
acaricide can be restored, and to explore their activity in inhibiting
specific metabolic pathways.
Materials and Methods
Source of Mites
Live scabies mites (Sarcoptes scabiei) were collected from two
sources: permethrin naı¨ve mites (Sarcoptes scabiei var. suis) were
collected from a colony maintained on pigs (Kelly, A. unpublished)
while permethrin resistant mites (Sarcoptes scabiei var. canis) that had
been maintained under permethrin treatment for many years were
collected from rabbits [12,13]. The establishment of mite colony
on pigs was approved by the Animal Ethics Committee of the
Department of Primary Industries and Fisheries, Queensland
adhering to the Institution’s guidelines for animal research.
Rabbits were maintained under a protocol approved by the
Wright State University Laboratory Animal Care and Use
Committee in adherence to institutional guidelines for animal
husbandry. Mites were used live immediately in bioassays or
collected and stored at 280uC until use in enzyme inhibition
assays.
Chemicals and Reagents
Synergists used in the bioassays and biochemical assays were:
Piperonyl Butoxide (PBO- Sigma, Milwaukee, WI); Diethyl
Maleate (DEM- Sigma, Milwaukee, WI); and S,S,S tributylpho-
sphorotrithioate (DEF- ChemServices West Chester, PA). All
other chemicals and reagents used in enzyme assays were
purchased from Sigma.
Reagents used in the bioassays were: 5% Permethrin (Elimite
Cream- DSM Pharmaceuticals Inc, Greenville, NC); Benzyl
Benzoate (Ascabiol Lotion- Aventis Pharma Pty Ltd, Lane Cove,
NSW); and mineral oil (Sigma).
Bioassays
In preliminary experiments, a small number of mites (30/
synergist) were exposed to each synergist alone (serially diluted
starting from 300 mM) to determine maximum concentration that
the mites could tolerate and remain alive for 24 hours (data not
shown). The result of this preliminary experiment led us to select a
concentration (30 mM) of each synergist for use in subsequent
bioassays.
Author Summary
Synergists are commonly used in combination with
pesticides to suppress metabolism-based resistance and
increase the efficacy of the agents. They are also useful as
tools for laboratory investigation of specific resistance
mechanisms based on their ability to inhibit specific
metabolic pathways. To determine the role of metabolic
degradation as a mechanism for acaricide resistance in
human scabies, PBO (piperonyl butoxide), DEF (S,S,S-
tributyl phosphorotrithioate) and DEM (diethyl maleate)
were used with permethrin as synergists in a bioassay of
mite killing. A statistically significant difference in survival
time of permethrin-resistant Sarcoptes scabiei variety canis
was noted when any of the three synergists were used in
combination with permethrin compared to survival time of
mites exposed to permethrin alone (p,0.0001). These
results indicate the potential utility of synergists in
reversing tolerance to pyrethroid-based acaricides (i.e.
the addition of synergists to permethrin-containing topical
acaricide cream commonly used to treat scabies). To
further verify specific metabolic pathways being inhibited
by these synergists, enzyme assays were developed to
measure esterase, glutathione S-transferase (GST) and
cytochrome P450 monooxygenase activity in scabies
mites. Results of in vitro enzyme inhibition experiments
showed lower levels of esterase activity with DEF; lower
levels of GST activity with DEM and lower levels of
cytochrome monooxygenase activity with PBO. These
findings indicate a metabolic mechanism as mediating
pyrethroid resistance in scabies mites.
Synergists in Pyrethroid-Resistant Scabies Mites
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Acaricide bioassays were performed on live scabies mites as
previously described [12] with some modifications. Briefly,
acaricide and synergists were spread thinly on plastic petri dishes
and then groups of female scabies mites were placed in the dish.
Mites were exposed to 5% Permethrin alone, 30 mM of each
synergist alone (PBO, DEF and DEM), 30 mM of each synergist
alone (PBO, DEF or DEM) plus 5% Permethrin, Benzyl Benzoate
(positive control acaricide) and mineral oil (negative control) for
24 hours. Petri dishes containing the mites were held in a 28uC
incubator at 100% relative humidity. The mites were held at 28uC
because lower temperature and higher relative humidity have been
found to favour survival of mites outside the host [14]. Individual
mites were observed at hourly intervals for 24 hours under a
microscope. The time of death, defined as complete absence of
movement and a cessation of peristalsis of the gut was recorded. A
total of 100 mites in each treatment group were assayed in each set
of synergist bioassay. Survival times of mites in acaricide and
controls were analysed using Survival Analysis in Graph Pad Prism
Figure 1. Survival of Permethrin (P) Resistant (Res) and Sensitive (Sen) Mites with or without Synergists. A. Survival of scabies mites
using PBO (Piperonyl Butoxide) as synergist to permethrin. B. Survival of scabies mites using DEF (S,S,S-tributylphosphorotrithioate) as synergist to
permethrin. C. Survival of scabies mites using DEM (Diethyl Maleate) as synergist to permethrin. Benzyl Benzoate was used as positive control and
Mineral Oil was used as negative control. Synergist (PBO, DEF and DEM) only controls were also included in the bioassays.
doi:10.1371/journal.pntd.0000354.g001
Synergists in Pyrethroid-Resistant Scabies Mites
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4. Kaplan-Meier survival curves of mites in each treatment group
were generated and statistical significance of differences in survival
curves determined by logrank test.
Enzyme Inhibition Assays
Preparation of mite homogenate. Scabies mites were
homogenized on ice in 100 ul 0.02M phosphate buffer pH 7.0
(esterase assay), 0.05M Tris-HCl buffer pH 7.5 (GST assay) or
0.1M sodium phosphate buffer pH 7.6 (cytochrome P450 assay),
using a hand-held battery operated homogenizer (Kontes Glass
Company, Vineland, NJ). After homogenization, the tubes were
spun at 13,0006g at 4uC for 5 minutes. Mites used for cytochrome
P450 assay were spun at 10006g at 4uC for 15 mins. The protein
concentration of the lysate was determined using the Nanodrop
ND-100 Spectrophotometer (Nanodrop Technologies,
Wilmington, DE, USA). Mite homogenates used in all enzyme
assays were normalized to 2 mg/ml protein concentration.
In vitro enzyme inhibition. Twenty microliters of mite
homogenate supernatant was incubated with varying dilutions
(30 mM, 15 mM, 8 mM and 4 mM) of enzyme inhibitors (PBO,
DEF and DEM) for 30 minutes at room temperature. Enzyme
assays were performed as outlined below:
Esterase Assay
Esterase activity was determined using alpha-napthyl acetate as
the substrate which forms a diazo-dye complex with Fast Blue RR
Salt. Colorimetric formation of the complex is directly propor-
tional to esterase activity and is measured continuously in a kinetic
assay as described by Gunning et al, 1996 [15] with some
modifications:
To mite homogenate (with and without inhibitor) set up in
triplicate, 200 ul of substrate (6 mg of Fast Blue dissolved in 10 ml of
0.2M phosphate buffer pH 6.0+100 ul of 100 mM alpha-naphthyl
acetate in acetone) was added. Change in absorbance was measured
at 450 nm at 14 second intervals for 10 minutes in a kinetic
microplate reader (POLARstar Optima, BMG LabTech). As an
assay control, esterase from rabbit liver, diluted 1:10 ((0.10 mg/ml)
and 1:100 (0.01 mg/ml) was included in each experiment.
Glutathione S-Transferase Assay
GST activity was measured by using monochlorobimane (MCB) as
the substrate which forms a stable fluorescent conjugate with reduced
glutathione. The enzymatic conversion of MCB to bimane-
glutathione is measured in an endpoint fluorescence assay as
described by Nauen and Stumpf, 2002 [16] with some modifications:
To mite homogenate (with and without inhibitor) set up in
triplicate, 200 ul of substrate (3 mg reduced glutathione dissolved
in 10 ml of 0.05M Tris-HCl buffer pH 7.5+500 ul of 1.5 mg/ml
of monochlorobimane (MCB) in methanol) was added. Mite
homogenate and substrate were incubated for 20 minutes at room
temperature. Fluorescence intensity was read on a microplate
reader (Polarstar) with 465 Emission and 390 Excitation filters. As
an assay control, GST from equine liver, diluted 1:10 (0.10 mg/
ml) and 1:100 (0.01 mg/ml) was included in each experiment.
Cytochrome P450 Assay
Cytochrome P450 activity was measured by using 7-ethoxy
coumarin as the substrate which results in a fluorescent 7-
hydroxycoumarin. The O-deethylation of 7-EC is measured in an
endpoint fluorescent assay as described by Stumpf and Nauen,
2001 [17] with some modifications:
To mite homogenate (with and without inhibitor) set up in
triplicate, 40 ul of 0.1M sodium phosphate buffer pH 7.6, 2 ul of
20 mM 7-EC in acetone and 10 ul of 10 mM Aqueous NADPH
was added. The enzyme and substrate reaction mixture was
incubated for 30 mins at 30uC with shaking. Excess NADPH was
removed by adding 10 ul of 100 mM oxidized glutathione and
13 ul of 10 U/ul of glutathione reductase and the reaction
incubated for 10 mins at room temperature. Fluorescence
intensity was read immediately after incubation using 465
Emission and 390 Excitation filters in a microplate reader
(Polarstar). As an assay control, human Cytochrome P450 isoform
diluted 1:10 (0.10 mg/ml) and 1:100 (0.01 mg/ml) was included in
each experiment.
Results
Bioassays
Survival time of both permethrin susceptible and permethrin
resistant mites over the 24-hour exposure to acaricide and
acaricide+/2synergist are shown in Figure 1A–C and median
survival times are listed in Table 1. Both resistant and sensitive
mites (100%) died within minutes of contact with benzyl benzoate
(positive control acaricide) while 98% of mites exposed to mineral
oil (negative control) and 97% of mites exposed to synergists alone
remained alive throughout the 24-hour observation period. A
significant reduction in survival time of resistant mites was
observed (p,0.0001) when exposed to permethrin in combination
with PBO (median survival = 4 hours) as compared to survival
time when exposed to permethrin alone (median survival = 15
hours) (Fig. 1A). A similar result was observed when resistant mites
were exposed to permethrin in combination with DEF (Fig. 1B),
with a median survival reduced from 15 to 6 hours (p,0.0001).
Similarly, the median survival of the resistant mites was
significantly reduced to 3 hours (p,0.0001) when DEM was used
as a synergist (Fig. 1C). In contrast, median survival time of
permethrin susceptible pig scabies mites exposed to permethrin
and permethrin in combination with PBO, DEF and DEM did not
show significant differences (p = 0.128; p = 0.465; p = 0.220,
respectively). Of note, the median survival (4 hours) of resistant
mites in permethrin+PBO was identical to the median survival of
sensitive mites exposed to permethrin alone suggesting complete
reversal of the resistance phenotype using PBO as synergist.
Enzyme Inhibition Assays
To investigate possible metabolic pathways inhibited by
synergists, enzyme inhibition assays were performed. Homogenate
supernatant from resistant mites were incubated with the
synergists (PBO, DEF, DEM) acting as inhibitor and enzyme
levels were compared with and without inhibitors. Homogenate
supernatants from susceptible mites were also incubated with the
synergists for comparison. Enzyme inhibition experiments were
Table 1. Median survival (hrs) of sensitive and resistant mites
in permethrin with and without synergist.
Treatment Sensitive mites Resistant mites
Permethrin 4 15
P+PBO 4 4*
P+DEF 3.5 6*
P+DEM 2 3*
*Significant differences in median survival of resistant mites in permethrin and
permethrin+synergist by log rank test (p,0.0001).
doi:10.1371/journal.pntd.0000354.t001
Synergists in Pyrethroid-Resistant Scabies Mites
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repeated several times and showed consistent results. Significant
differences in enzyme activities with and without inhibitors were
determined by t test.
Esterase Inhibition by Synergists
Esterase activity in resistant scabies mites was significantly
inhibited by DEF (36%; p,0.0001), and to lesser degree by PBO
(16%; p = 0.006). Inhibition of esterase activity in resistant mites
by DEM was unremarkable (0.6%; p = 0.507). A decrease in
esterase activity was likewise observed in susceptible mites with
PBO, DEF and DEM. However, the decrease was not statistically
significant (p = 0.337; p = 0.280; p = 0.443, respectively) (Fig. 2A).
Varying concentrations of DEF did not alter esterase activity in
resistant mites (Fig. 3). Esterase activity levels in resistant mites was
7-fold (p,0.0001) higher than in sensitive mites.
GST Inhibition by Synergists
GST levels of resistant scabies mites were significantly inhibited
by DEM (73%; p,0.0001) and to lesser degree by PBO (18.0%;
p = 0.017) and DEF (17.5%; p = 0.018). PBO, DEF and DEM
decreased GST activity in sensitive mites but the decrease was not
statistically significant (p = 0.219; p = 0.094; p = 0.065, respective-
ly) (Fig. 2B). A dose-dependent inhibition of GST activity by DEM
was also observed in the resistant mites with maximum effect at
30 mM concentration. GST activity was observed to return to
uninhibited level at 4 mM concentration of DEM (Fig. 4). A 4-fold
(p,0.0001) increase in GST levels was observed in resistant mites
compared to sensitive mites.
Cytochrome P450
Cytochrome P450 monooxygenase activity in resistant mites
was significantly inhibited by PBO (81%; p,0.0001), DEF (65%;
p = 0.0073) and DEM (49%; p = 0.0003) at 3mM concentration.
In sensitive mites, CYP450 monooxygenase activity is significantly
inhibited by DEM (34%; p,0.02); by DEF (24%; p = 0.03) and
PBO (21%; p = 0.04) at the same concentration of inhibitor
(Fig. 2C). Results of CYP450 inhibition in resistant and sensitive
mites are unremarkable at 30 mM concentration of inhibitor. A
Figure 3. Esterase levels of resistant mites with varying concentrations of DEF. *Error bars represent SEM. **Commercial esterase from
rabbit liver was used as assay control.
doi:10.1371/journal.pntd.0000354.g003
Figure 4. GST levels of resistant mites with varying concentrations of DEM. *Error bars represent SEM. **Commercial GST from equine liver
was used as assay control.
doi:10.1371/journal.pntd.0000354.g004
Figure 2. Results of in-vitro enzyme inhibition by synergists/inhibitors (30 mM). A. Esterase activity in resistant and sensitive scabies mites
in the presence or absence of inhibitor (PBO, DEF and DEM). B. GST activity in resistant and sensitive mites in the presence or absence of inhibitor
(PBO, DEF and DEM). C. Cytochrome P450 activity in the presence or absence of inhibitor (PBO, DEF and DEM). *Error bars represent SEM.
doi:10.1371/journal.pntd.0000354.g002
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2.4-fold (p = 0.0002) increase in cytochrome P450 monoxygenase
activity was observed in resistant mites compared to sensitive
mites.
Discussion
Detoxifying enzymes and target alteration are equally important
mechanisms of insecticide degradation in ticks and mites. While a
point mutation in the Vssc gene has been associated with
pyrethroid resistance in two strains of cattle ticks, Boophilus
microplus, high levels of esterase activity have been observed in
another two strains in the absence of this mutation [5]. Resistance
to tau-fluvalinate in the honeybee mite, Varroa destructor has been
associated with sodium channel insensitivity as well as elevated
cytochrome P450s and high levels of esterases [18,19].
We have previously addressed target alteration as a mechanism
of pyrethroid resistance in scabies mites. A non-synonymous SNP
was identified in the kdr gene associated with permethrin
resistance, in the population of Sarcoptes scabiei var canis mites
studied here and developed a highly sensitive high resolution melt
(HRM) assay for its detection [12]. In this study, further
investigation was done to verify if the resistance phenotype may
also be mediated by detoxifying enzymes, hypothesizing that
multiple mechanisms may be present as had been reported in the
cattle ticks and honeybee mites.
To better understand metabolic mechanisms of pyrethroid
resistance in Sarcoptes scabiei mites, commonly used synergists PBO,
DEF and DEM were used in acaricide bioassays. Enzyme assays
were performed using three biochemical markers such as esterases,
GSTs and cytochrome P450s linked to insecticide resistance to
further define specific metabolic pathways inhibited in a
population of resistant scabies mites.
In this study, significantly higher levels of esterase, GST and
cytochrome P450 monooxygenase activity in resistant mites were
observed when compared to sensitive mites suggesting metabolic
degradation as a mechanism of pyrethroid resistance in this
population of scabies mites. It was also observed that PBO, DEF
and DEM when used as synergists to permethrin in bioassays,
significantly decreased the survival times of resistant mites. These
findings are in agreement with results of enzyme inhibition
experiments that showed inhibition of cytochrome P450 mono-
oxygenase activity (81%) by PBO, inhibition of GST activity (73%)
by DEM and inhibition of . esterase activity (36%) by DEF when
homogenate supernatant of resistant mites were incubated with
the synergists. These results suggest possible roles of GSTs,
esterases and cytochrome P450 monooxygenases in detoxifying
permethrin in this population of resistant mites.
In initial assays of cytochrome P450 we failed to detect enzyme
activity in both sensitive and resistant mites using homogenates
spun at high speed. However, in subsequent assays using mite
homogenate spun at a much lower speed (10006g), positive results
were observed [20]. This change in methodology is based on the
hypothesis that mites maybe similar to insects in that monooxy-
genase activity is primarily present in the microsomes; released out
of the endoplasmic reticulum by mechanical homogenisation [21]
and lower centrifugation allows the microsomes to stay in solution
to be used in the assay. The cytochrome levels detected in resistant
mites was significantly inhibited by all three synergists with the
greatest inhibition achieved by PBO at a much lower concentra-
tion. These findings suggest oxidative metabolism catalysed by
P450’s may also be an important route for the detoxification of
pyrethroids in this population of resistant mites.
Overall, these findings have demonstrated potential utility of
synergists in reversing resistance to acaricide and validated
metabolic mechanisms of pyrethroid resistance in scabies mites.
The results of this study also support our hypothesis that
permethrin resistance in this population of scabies mites may be
mediated by multiple mechanisms including target alteration, as
demonstrated in our previous study [12], and by metabolic
degradation, as demonstrated in this study.
The addition of a synergist to topical creams containing
permethrin as the active ingredient may result in better clinical
management of acaricide resistant scabies. Improved management
of permethrin resistant head lice infestations has already been
achieved by adding PBO as a synergist to pyrethrin based head
lice shampoos and are now available as over the counter products
[8].
This work now leads us to consider undertaking in-vitro
susceptibility and pesticide synergist studies on clinical isolates
from scabies-endemic communities in remote Aboriginal commu-
nities in Northern Australia where mass drug administration is
underway. These studies will determine the potential role of
metabolic degradation as a mechanism of permethrin resistance in
human scabies mites.
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